Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Hypertension. 2009 May 26;54(1):47–56. doi: 10.1161/HYPERTENSIONAHA.109.129841

Table 2.

Percentage of NHANES 1999–2006 participants with hypertension who have uncontrolled blood pressure, by presence of CKD (stages 3 and 4) and definition of uncontrolled blood pressure (general vs. disease-specific)

% with Uncontrolled Blood Pressure (95% CI)
General Definition
(≥140/≥90 mmHg)
Disease-specific Definition
(≥130/≥85 [1999–2002] and ≥130/≥80 [2003–2006] mmHg for
CKD & diabetes; otherwise ≥140/≥90 mmHg)

No CKD (n=5163) CKD (Stage 3 & 4; n=1330) No CKD (n=5163) CKD (Stage 3 & 4; n=1330)

Subgroup Unadjusted Adjusted* Unadjusted Adjusted* Unadjusted Adjusted* Unadjusted Adjusted*
Overall 48.7 (46.3–51.1) 52.7 (50.4–55.0) 51.5 (48.5–54.6) 59.0 (56.2–61.7) 51.7 (49.3–54.2) 58.6 (56.3–60.9) 68.8 (65.7–71.8) 69.2 (66.6–71.7)
Survey Year
 1999–2002 53.4 (50.0–56.7) 56.3 (52.7–60.0) 55.9 (51.3–60.3) 59.2 (53.7–64.4) 56.4 (53.0–59.7) 60.8 (57.3–64.2) 71.8 (67.5–75.8) 74.7 (70.1–78.7)
 2003–2006 44.3 (41.1–47.6) 50.0 (46.9–53.1) 47.8 (43.7–52.0) 50.9 (46.1–55.8) 47.3 (44.1–50.6) 54.1 (50.9–57.2) 66.3 (61.6–70.6) 70.7 (66.2–74.8)
P for trend <0.001 0.011 0.011 0.027 <0.001 0.007 0.073 0.204
Demographics
Age
 20–39 38.5 (33.9–43.4) 34.7 (31.3–38.2) 49.9 (31.3–68.4) 32.2 (21.9–44.7) 39.7 (34.9–44.6) 38.7 (35.2–42.3) 69.7 (47.8–85.2) 51.3 (37.2–65.2)
 40–59 46.0 (43.0–49.0) 47.4 (44.8–50.0) 37.2 (28.4–46.9) 40.0 (32.5–49.2) 49.0 (45.9–52.0) 51.7 (49.2–54.2) 54.7 (44.1–64.9) 60.2 (51.2–68.5)
 60–69 51.7 (47.5–55.8) 60.4 (58.0–62.9) 46.4 (38.8–54.1) 49.6 (44.7–54.4) 57.0 (52.7–61.2) 64.5 (62.1–66.8) 66.8 (59.5–73.3) 68.4 (64.2–72.3)
 70+ 63.8 (60.0–67.4) 72.1 (69.1–75.1) 57.2 (58.5–60.8) 58.5 (54.7–62.3) 66.5 (63.0–69.9) 75.5 (72.5–78.2) 73.5 (69.8–76.8) 75.6 (71.9–78.9)
P for trend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.002 0.002
Sex
 Male 47.7 (44.6–50.8) 53.0 (49.9–56.1) 46.5 (41.1–52.0) 49.8 (43.9–55.6) 50.3 (47.2–53.4) 57.0 (53.7–60.2) 64.5 (59.0–69.6) 69.1 (63.7–74.0)
 Female 49.8 (47.1–52.5) 52.8 (49.7–55.9) 54.0 (50.5–58.6) 58.4 (53.6–63.0) 53.3 (50.6–55.9) 57.4 (54.6–60.2) 71.4 (67.1–75.5) 75.1 (70.2–79.4)
P for trend 0.212 0.921 0.028 0.030 0.071 0.811 0.060 0.119
Race
 Non-Hispanic White 46.7 (43.9–49.5) 49.4 (46.6–52.1) 51.4 (48.0–54.8) 53.6 (49.6–57.6) 49.3 (46.4–52.2) 53.4 (50.7–56.1) 67.8 (64.4–71.1) 70.1 (66.8–73.3)
 Non-Hispanic Black 53.6 (50.6–56.6) 53.5 (51.0–56.0) 52.0 (44.4–59.5) 55.3 (50.4–60.1) 57.5 (54.3–60.6) 57.8 (55.4–60.2) 70.5 (63.3–76.8) 74.5 (70.7–78.5)
 Mexican- American 53.3 (49.3–57.3) 57.5 (53.3–61.7) 51.0 (37.7–64.1) 56.9 (47.9–65.5) 57.6 (53.6–61.4) 62.0 (58.1–65.8) 64.0 (51.0–75.2) 79.0 (72.1–84.5)
P for trend <0.001 0.002 0.986 0.509 <0.001 0.001 0.609 0.020
Socioeconomic Status
Education
 <High school 55.8 (52.6–59.0) 54.7 (51.3–57.9) 51.4 (45.5–57.3) 52.4 (46.1–58.7) 59.7 (56.5–62.9) 58.7 (55.4–62.0) 69.3 (63.6–74.4) 70.2 (64.7–75.2)
 High school+ 46.7 (44.0–49.4) 52.0 (48.8–55.2) 51.5 (47.5–55.5) 55.6 (50.6–60.5) 49.5 (46.7–52.3) 56.4 (53.2–59.6) 68.6 (64.1–72.8) 73.6 (68.8–77.9)
P for trend <0.001 0.263 0.981 0.459 <0.001 0.347 0.863 0.384
Household income
 <$20,000 53.4 (49.1–57.5) 54.7 (51.1–58.3) 55.6 (49.8–61.2) 56.3 (50.8–61.7) 57.6 (53.9–61.2) 59.5 (55.8–63.0) 71.8 (66.5–76.7) 74.3 (69.8–78.4)
 $20–44,999 50.0 (46.6–53.5) 53.4 (50.9–55.8) 50.5 (43.2–57.8) 54.5 (50.8–58.1) 54.1 (50.4–57.7) 57.8 (55.3–60.2) 69.9 (63.3–75.7) 72.4 (69.3–75.4)
 $45–74,999 48.4 (43.8–52.9) 52.0 (49.1–54.9) 49.6 (42.5–56.7) 52.6 (46.8–58.4) 50.0 (45.6–54.4) 56.0 (53.3–58.7) 66.5 (58.2–73.8) 70.4 (65.6–74.8)
 $75,000+ 41.3 (37.0–45.8) 50.7 (46.2–55.1) 43.7 (32.7–55.3) 50.8 (41.2–60.2) 43.4 (39.0–47.9) 54.3 (50.0–58.5) 59.0 (47.7–69.4) 68.4 (60.3–75.5)
P for trend <0.001 0.222 0.305 0.397 <0.001 0.107 0.170 0.235
Insurance
 No 48.4 (45.9–50.9) 52.9 (50.3–55.6) 51.4 (48.3–54.6) 54.4 (50.7–58.1) 51.6 (49.0–54.2) 57.4 (54.6–60.1) 68.7 (65.5–71.6) 72.2 (69.1–75.2)
 Yes 50.5 (44.7–56.3) 52.7 (46.0–59.4) 46.8 (27.5–67.2) 54.8 (29.1–78.2) 52.6 (46.8–58.2) 56.2 (49.4–62.7) 68.9 (47.7–84.3) 76.6 (52.6–90.6)
P for trend 0.488 0.954 0.668 0.978 0.744 0.759 0.980 0.672
Clinical Status
BMI
 <30 51.5 (48.4–54.5) 52.7 (49.5–55.9) 53.7 (49.6–57.7) 54.8 (50.4–59.1) 52.9 (50.0–55.9) 56.5 (53.5–59.4) 69.9 (66.0–73.6) 72.3 (68.3–76.0)
 30+ 45.1 (42.1–48.0) 53.2 (50.0–56.2) 48.8 (43.2–54.6) 53.8 (47.0–60.5) 50.0 (46.8–53.2) 58.2 (54.9–61.4) 67.0 (62.1–71.5) 72.5 (67.6–77.0)
P for trend <0.001 0.845 0.193 0.821 0.119 0.424 0.286 0.941
Diabetes
 No 40.9 (36.9–45.1) 46.0 (41.6–50.6) 52.3 (44.8–59.7) 61.2 (53.0–68.9) 65.4 (60.1–70.4) 72.8 (68.1–77.0) 66.0 (58.9–72.4) 72.4 (65.5–78.3)
 Yes 49.9 (47.4–52.4) 54.1 (51.6–56.5) 51.5 (47.9–55.2) 52.2 (48.0–56.4) 49.9 (47.4–57.4) 54.3 (51.9–56.6) 69.4 (65.6–72.9) 72.4 (68.3–76.2)
P for trend <0.001 0.001 0.868 0.059 <0.001 <0.001 0.404 0.989
Albuminuria
 No 47.0 (44.4–49.5) 49.3 (46.6–52.0) 46.7 (42.6–50.5) 47.0 (42.6–51.4) 49.6 (46.9–52.3) 53.8 (51.0–56.6) 64.0 (59.9–68.0) 65.5 (61.8–69.3)
 Yes 63.1 (59.6–66.4) 65.5 (61.6–69.2) 66.7 (60.1–72.8) 68.2 (42.6–51.3) 68.8 (65.5–72.0) 67.0 (62.6–70.9) 81.8 (76.9–85.8) 83.2 (78.1–87.4)
P for trend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Treatment Status Any anti-hypertensive
 No 59.3 (56.7–61.9) 64.4 (61.6–67.2) 71.1 (64.4–77.1) 73.4 (66.6–79.2) 61.2 (58.5–63.8) 68.4 (65.8–71.0) 84.0 (79.0–88.0) 84.7 (79.7–88.7)
 Yes 35.8 (32.9–38.7) 35.2 (32.0–38.5) 43.1 (39.5–46.7) 44.9 (41.1–48.8) 40.2 (37.1–43.4) 38.9 (35.7–42.3) 62.3 (58.8–65.7) 65.1 (61.5–68.4)
P for trend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Number of anti- hypertensives
 0 59.3 (56.7–61.9) 61.3 (58.4–64.1) 71.1 (64.4–77.1) 68.0 (62.9–72.7) 61.2 (58.5–63.8) 75.1 (68.1–80.9) 84.0 (79.0–88.0) 80.4 (76.7–83.8)
 1 33.9 (30.5–37.5) 43.6 (40.8–46.5) 44.4 (39.4–49.5) 53.1 (49.7–56.7) 37.7 (34.2–41.3) 64.4 (57.4–70.9) 63.4 (58.9–67.7) 71.3 (68.3–74.1)
 2+ 40.9 (35.5–46.4) 27.4 (23.1–32.2) 40.9 (35.5–46.5) 37.8 (33.0–42.8) 47.0 (41.5–52.6) 52.2 (43.6–60.6) 60.4 (54.4–66.1) 59.9 (54.6–65.0)
P for trend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
ACE inhibitors/ARBs
 No 52.2 (49.7–54.6) 54.8 (52.0–57.5) 55.6 (51.6–59.5) 56.5 (52.4–60.7) 54.7 (52.3–57.0) 67.3 (59.9–74.0) 72.0 (67.8–75.8) 73.2 (69.1–76.8)
 Yes 33.1 (29.0–37.6) 35.2 (30.6–40.1) 39.6 (34.5–45.0) 43.3 (37.5–49.3) 38.6 (34.1–43.3) 57.5 (49.1–65.4) 59.6 (53.9–65.1) 64.1 (58.6–69.3)
P for trend <0.001 <0.001 <0.001 0.001 <0.001 0.016 0.002 0.016
Diuretic
 No 50.9 (48.5–53.2) 53.3 (50.7–55.8) 53.1 (49.8–56.4) 54.5 (51.0–58.0) 53.8 (51.4–56.3) 66.1 (59.0–72.5) 70.0 (66.6–73.2) 71.8 (68.2–75.1)
 Yes 34.8 (30.3–39.6) 36.9 (32.2–41.8) 45.2 (39.4–51.2) 47.1 (39.5–54.7) 38.0 (33.3–43.0) 60.5 (50.4–69.7) 64.1 (56.7–70.8) 66.6 (59.0–73.5)
P for trend <0.001 <0.001 0.016 0.076 <0.001 0.219 0.115 0.219
Other anti-hypertensive
 No 49.0 (46.6–51.4) 51.4 (49.0–54.0) 51.3 (48.1–54.5) 52.6 (49.2–56.1) 52.0 (49.6–54.5) 64.8 (57.9–71.1) 69.0 (65.6–72.1) 70.8 (67.6–73.7)
 Yes 40.4 (31.4–50.1) 39.1 (29.2–50.2) 56.5 (45.9–66.6) 61.7 (47.9–73.8) 43.8 (34.5–53.5) 65.7 (50.3–78.4) 66.2 (55.5–75.4) 71.6 (58.0–82.2)
P for trend 0.084 0.026 0.347 0.208 0.099 0.894 0.603 0.894

ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.

*

Adjusted for all of the following except the subgroup being examined: survey year, age, sex, race, education, income, insurance, obesity, diabetes, and treatment with any anti-hypertensive.

Includes beta and calcium channel blockers.